相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In Vivo Correction of COX Deficiency by Activation of the AMPK/PGC-1α Axis
Carlo Viscomi et al.
CELL METABOLISM (2011)
A metabolic shift induced by a PPAR panagonist markedly reduces the effects of pathogenic mitochondrial tRNA mutations
Tina Wenz et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Peroxisome-Proliferator-Activated Receptor Gamma Coactivator 1 α Contributes to Dysmyelination in Experimental Models of Huntington's Disease
Zhongmin Xiang et al.
JOURNAL OF NEUROSCIENCE (2011)
Truncated Peroxisome Proliferator-Activated Receptor-γ Coactivator 1α Splice Variant Is Severely Altered in Huntington's Disease
Ashu Johri et al.
NEURODEGENERATIVE DISEASES (2011)
Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease
Daniel J. Ho et al.
EXPERIMENTAL NEUROLOGY (2010)
Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease
Cliona Stack et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease
Jinho Kim et al.
HUMAN MOLECULAR GENETICS (2010)
Modulation of energy deficiency in Huntington's disease via activation of the peroxisome proliferator-activated receptor gamma
Ming-Chang Chiang et al.
HUMAN MOLECULAR GENETICS (2010)
Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation
Rajnish K. Chaturvedi et al.
HUMAN MOLECULAR GENETICS (2010)
Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse models
Jack Phan et al.
HUMAN MOLECULAR GENETICS (2009)
Impaired PGC-1α function in muscle in Huntington's disease
Rajnish K. Chaturvedi et al.
HUMAN MOLECULAR GENETICS (2009)
PGC-1α and PGC-1β Regulate Mitochondrial Density in Neurons
Przemyslaw Wareski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The gene coding for PGC-1α modifies age at onset in Huntington's Disease
Patrick Weydt et al.
MOLECULAR NEURODEGENERATION (2009)
PGC-1 alpha as modifier of onset age in Huntington disease
Elahe Taherzadeh-Fard et al.
MOLECULAR NEURODEGENERATION (2009)
Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin
Shu-ichi Okamoto et al.
NATURE MEDICINE (2009)
Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models
Liliana Menalled et al.
NEUROBIOLOGY OF DISEASE (2009)
Evidence of Oxidant Damage in Huntington's Disease: Translational Strategies Using Antioxidants
Edward C. Stack et al.
MITOCHONDRIA AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISORDERS (2008)
被撤回的出版物: Activation of the PPAR/PGC-1α pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype (Retracted article. See vol. 24, pg. 889, 2016)
Tina Wenz et al.
CELL METABOLISM (2008)
Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells -: Possible role of peroxisome proliferator-activated receptor-γ (PPARγ) in the pathogenesis of Huntington disease
Rodrigo A. Quintanilla et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Activation of peroxisome proliferator-activated receptor pathway stimulates the mitochondrial respiratory chain and can correct deficiencies in patients' cells lacking its components
Jean Bastin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice
Michelle Gray et al.
JOURNAL OF NEUROSCIENCE (2008)
Clinical correlates of mitochondrial function in Huntington's disease muscle
Christopher Turner et al.
MOVEMENT DISORDERS (2007)
Myopathy as a first symptom of Huntington's disease in a marathon runner
Christoph M. Kosinski et al.
MOVEMENT DISORDERS (2007)
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α
Marie Lagouge et al.
CELL (2006)
Oxidative damage in Huntington's disease pathogenesis
Susan E. Browne et al.
ANTIOXIDANTS & REDOX SIGNALING (2006)
Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1α in Huntington's disease neurodegeneration
Patrick Weydt et al.
CELL METABOLISM (2006)
Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators
Julie St-Pierre et al.
CELL (2006)
Transcriptional repression of PGC-α by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration
Libin Cui et al.
CELL (2006)
Thiazolidinediones and rexinoids induce peroxisome proliferator-activated receptor-coactivator (PGC)-1α gene transcription:: An autoregulatory loop controls PGC-1α expression in adipocytes via peroxisome proliferator-activated receptor-γ coactivation
Elayne Hondares et al.
ENDOCRINOLOGY (2006)
Low stability of Huntington muscle mitochondria against Ca2+ in R6/2 mice
ZZ Gizatullina et al.
ANNALS OF NEUROLOGY (2006)
Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2′dG
SM Hersch et al.
NEUROLOGY (2006)
Metabolic control through the PGC-1 family of transcription coactivators
JD Lin et al.
CELL METABOLISM (2005)
Tryptophan metabolism and oxidative stress in patients with Huntington's disease
N Stoy et al.
JOURNAL OF NEUROCHEMISTRY (2005)
PGC-1α deficiency causes multi-system energy metabolic derangements:: Muscle dysfunction, abnormal weight control and hepatic steatosis
TC Leone et al.
PLOS BIOLOGY (2005)
Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons
Alexander Tenenbaum et al.
CARDIOVASCULAR DIABETOLOGY (2005)
The energetics of Huntington's disease
SE Browne et al.
NEUROCHEMICAL RESEARCH (2004)
Endogenous mitochondrial oxidative stress: neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice
D Hinerfeld et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Nuclear receptor signaling and cardiac energetics
JM Huss et al.
CIRCULATION RESEARCH (2004)
Chemotherapy for the brain: The antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease
RJ Ferrante et al.
JOURNAL OF NEUROSCIENCE (2004)
Brown adipose tissue: Function and physiological significance
B Cannon et al.
PHYSIOLOGICAL REVIEWS (2004)
Defects in adaptive energy metabolism with CNS-Linked hyperactivity in PGC-1α null mice
JD Lin et al.
CELL (2004)
Experimental therapeutics in transgenic mouse models of Huntington's disease
MF Beal et al.
NATURE REVIEWS NEUROSCIENCE (2004)
Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
J Lin et al.
NATURE (2002)
Rapid, fluorimetric-liquid chromatographic determination of malondialdehyde in biological samples
R Agarwal et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2002)
Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington's disease
OA Andreassen et al.
NEUROBIOLOGY OF DISEASE (2001)
分享论文
